Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 9,500 shares at $89.63 ($854K) on 2020-12-02, disclosed to the SEC on 2020-12-04.
Open-market sale of $854k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.63 | 3,798 | $340K | 39.9% |
| 2 | $89.63 | 3,798 | $340K | 39.9% |
| 3 | $90.63 | 702 | $64K | 7.4% |
| 4 | $90.63 | 702 | $64K | 7.4% |
| 5 | $91.89 | 300 | $28K | 3.2% |
| 6 | $92.97 | 200 |
| $19K |
| 2.2% |
| Total | $89.92 avg | 9,500 | $854K | 100% |
| Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |
| EIDX | SELL | 2019-09-27 | $96K | — | Filing → |